Condition

Non Small Cell Lung Cancer Metastatic

ClinicalTrials.gov condition label

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 54 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials54
Recruiting8
Common interventions25
Lead sponsors shown15
Advertisement

Clinical trials

54 shown
Observational Multicenter Study in Patients Receiving Chemotherapy and Amivantamab for Metastatic Non-small Cell Lung CancerNCT07563205 · 2025-11-19
RECRUITING
PALACE: Cemiplimab Trial According to ctDNA LevelsNCT06917573 · 2025-07-29
RECRUITING
First-line Therapy With Nivolumab Plus Ipilimumab in Combination With Chemotherapy for Metatastatic NSCLC (NICReWo Trial)NCT07190677 · 2025-01-17
RECRUITING
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the BrainNCT06741085 · 2024-12-13
RECRUITING
A Phase Ib Study of GC101 in NSCLCNCT06473961 · 2024-10-14
RECRUITING
Value of Screening MRI Brain in Stage IV Non-small Cell Lung CancerNCT05864794 · 2024-05-13
RECRUITING
A Study to Evaluate the Combination of Platinum-pemetrexed Based Chemotherapy Plus Lorlatinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) With Exclusively Extracranial Disease Progression on LorlatinibNCT06378892 · 2024-03-15
RECRUITING
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)NCT05657873 · 2022-12-09
RECRUITING
Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung DiseaseNCT07420439 · 2026-09-15
NOT_YET_RECRUITING
Phase III, Multicenter, Randomized Controlled Clinical Study of Three-Dimensional Radiotherapy for Primary Tumors in Non-Oligometastatic Stage IV Non-Small Cell Lung CancerNCT07462728 · 2026-03-30
NOT_YET_RECRUITING
Survival Efficacy of Combined Radiotherapy and Immunotherapy in Patients With Metastatic Non-small Cell Lung CarcinomaNCT07111104 · 2024-10-14
COMPLETED
JDQ443 for KRAS G12C NSCLC Brain MetastasesNCT05999357 · 2024-04-15
WITHDRAWN
Effect of DM on Outcomes and Response Rate in Patients With Advanced NSCLC on ICINCT06100796 · 2023-10-01
UNKNOWN
Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLCNCT05668650 · 2023-08-15
UNKNOWN
Liquid Biopsy Based NGS in Newly Diagnosed NSCLCNCT05853887 · 2023-06-15
ACTIVE_NOT_RECRUITING
A Biomarker Screening Protocol for Participants With Solid TumorsNCT05891197 · 2023-05-19
TERMINATED
Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004)NCT05599789 · 2023-02-01
ACTIVE_NOT_RECRUITING
A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)NCT05429320 · 2022-06-15
COMPLETED
A Study to Investigate LYL797 in Adults With Solid TumorsNCT05274451 · 2022-03-29
TERMINATED
Fecal Microbial Transplantation Non-Small Cell Lung Cancer and MelanomaNCT04951583 · 2021-11-16
UNKNOWN
Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung CancerNCT05117242 · 2021-10-27
TERMINATED
Lorlatinib After Failure of First-line TKI in Patients With Advanced ROS1-positive NSCLC (ALBATROS)NCT04621188 · 2021-03-19
ACTIVE_NOT_RECRUITING
Study to Investigate DRP-104 in Adults With Advanced Solid TumorsNCT04471415 · 2020-08-31
TERMINATED
Lorlatinib After Failure of First-line Second-generation ALK Kinase Inhibitor in Patients With Advanced ALK-positive Non-small Cell Lung CancerNCT04111705 · 2020-08-05
COMPLETED
Pharmacokinetic Characteristics, Safety, Tolerability and Immunogenicity of LY01008 and Avastin in Healthy Chinese Male SubjectsNCT05110118 · 2020-08-04
COMPLETED
Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR MutationNCT04233021 · 2020-07-16
COMPLETED
Immunological Profile Changes In Patients With Advanced Non-Small Cell Lung CancerNCT04187768 · 2019-11-26
COMPLETED
Thyroid Dysfunction and Nivolumab Reponse in NSCLCNCT04470440 · 2019-10-22
COMPLETED
Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILs™ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLCNCT04069936 · 2019-10-15
TERMINATED
Atezolizumab in Elderly Patients With Advanced Non-Small-Cell Lung Cancer and Receiving Carboplatin Paclitaxel ChemotherapyNCT03977194 · 2019-07-23
ACTIVE_NOT_RECRUITING
Her2-positive Lung Cancer Treated With Dedicated DrugNCT03845270 · 2019-05-17
COMPLETED
Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing CancerNCT03907852 · 2019-04-15
ACTIVE_NOT_RECRUITING
A Study to Evaluate Immunotherapy Combinations in Participants With Lung CancerNCT03846310 · 2019-04-01
COMPLETED
Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain MetastasesNCT03732482 · 2019-03-01
UNKNOWN
Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)NCT03715985 · 2019-01-28
UNKNOWN
Randomized Study of Stereotactic Body Radiation Therapy (SBRT) in Patients With Oligoprogressive Metastatic Cancers of the Breast and LungNCT03808662 · 2019-01-16
ACTIVE_NOT_RECRUITING
Phase I/II Study of Nivolumab and Ipilimumab Combined With Nintedanib in Non Small Cell Lung CancerNCT03377023 · 2018-02-02
ACTIVE_NOT_RECRUITING
PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung CancerNCT03774732 · 2018-01-24
ACTIVE_NOT_RECRUITING
A Study of ASN007 in Patients With Advanced Solid TumorsNCT03415126 · 2018-01-19
COMPLETED
A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With the Therapeutic Vaccine Named TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC)NCT03353675 · 2018-01-05
COMPLETED
First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2bNCT03319628 · 2017-12-12
ACTIVE_NOT_RECRUITING
First-in-Human Dose Escalation Study of XMT-1536 in Cancers Likely to Express NaPi2bNCT06517433 · 2017-12-12
COMPLETED
A Study of LY01008 and Bevacizumab Combined With Paclitaxel and Carboplatin for Treatment of Naïve Subjects With Metastatic or Recurrent Nonsquamous Non-small Cell Lung CancerNCT03533127 · 2017-11-27
UNKNOWN
Immunotherapy by Nivolumab for HIV+ PatientsNCT03304093 · 2017-10-19
COMPLETED
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042NCT03307785 · 2017-10-12
COMPLETED
Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)NCT03168464 · 2017-10-09
TERMINATED
CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With NivolumabNCT03123783 · 2017-07-10
COMPLETED
Combining Radiosurgery and Nivolumab in the Treatment of Brain MetastasesNCT02978404 · 2017-06-02
COMPLETED
Osimertinib and Bevacizumab Versus Osimertinib Alone as Second-line Treatment in Stage IIIb-IVb NSCLC With Confirmed EGFRm and T790MNCT03133546 · 2017-05-31
COMPLETED
Cancer Panel From Blood of Lung Cancer PatientsNCT03235765 · 2017-03-10
UNKNOWN
Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung CancerNCT03035890 · 2017-01-23
COMPLETED
Stereotactic Ablative Radiotherapy in Synchronous and Metachronous Oligo-Metastatic Non Small Cell Lung CancerNCT06207292 · 2016-12-01
UNKNOWN
Exercise Intervention During Chemotherapy in Advanced Lung Cancer PatientsNCT03334071 · 2014-04-04
UNKNOWN
5-Fluorouracil Followed by Interferon-alfa-2b in Previously-treated Metastatic Gastrointestinal, Kidney, or Lung CancerNCT01658813 · 2012-07-01
COMPLETED

Common interventions

Leading sponsors

Trial status mix

COMPLETED19
ACTIVE_NOT_RECRUITING9
UNKNOWN9
RECRUITING8
TERMINATED6
NOT_YET_RECRUITING2
WITHDRAWN1

Phase mix

PHASE229
PHASE114
NA6
PHASE35
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.